Nov 29, 2001 (CIDRAP News) The US Department of Health and Human Services (HHS) has awarded Acambis Inc. a $428 million contract to produce an additional 155 million doses of smallpox vaccine by the end of 2002, HHS Secretary Tommy G. Thompson announced Wednesday.
(CIDRAP News) Rapid tests for detecting anthrax spores on surfaces should not be used alone as the basis for public health or clinical decisions, the Centers for Disease Control and Prevention warned in today's issue of Morbidity and Mortality Weekly Report.
(CIDRAP News) The US House of Representatives on Wednesday overwhelmingly approved a bill authorizing about $2.9 billion in spending on preparedness for bioterrorism and other public health emergencies.
(CIDRAP News) Because of a small theoretical risk that anthrax spores can hide in the lungs for up to 100 days and grow after antibiotic treatment is stopped, the anthrax vaccine and an extension of antibiotic treatment will be offered to people who may have been exposed in the recent anthrax attacks, federal health officials announced yesterday afternoon.
Jan 2, 2001 (CIDRAP News) Aside from Capitol Hill staff members, only 52 of more than 3,500 people who have been offered the anthrax vaccine because of the recent mail attacks have decided to take it, according to the Centers for Disease Control and Prevention (CDC).
(CIDRAP News) – A new nuclear medicine technique using a radioisotope-labeled antibody has shown enough promise for early diagnosis of anthrax infection to gain the Food and Drug Administration's approval for a clinical trial, according to a recent report in the Journal of Nuclear Medicine.
(CIDRAP News) A recent analysis of ground pork in grocery stores in five states showed that 4% of the samples contained enterococci with high-level resistance to gentamicin, an antibiotic used to treat enterococcal infections in humans. In addition, most Enterococcus faecium isolates were resistant to quinupristin-dalfopristin (Synercid), a streptogramin antibiotic used to treat infections caused by vancomycin-resistant E faecium.
(CIDRAP News) Federal health officials revealed this week that they are working on a plan to use immune globulin derived from the blood of anthrax-vaccinated military personnel for emergency treatment of patients with severe cases of inhalational anthrax, if needed.
(CIDRAP News) Thousands of people who were potentially exposed to anthrax last fall will be interviewed over the next 8 weeks to assess the results of their postexposure antibiotic treatment, the Centers for Disease Control and Prevention (CDC) announced yesterday.
(CIDRAP News) The US Department of Health and Human Services (HHS) will soon release about 20% of the $1 billion in bioterrorism preparedness funding that is slated to go to states this year, HHS Secretary Tommy G. Thompson announced Jan 25.